Although obtained in a model of brain ischemia, it has been found that 3-hydroxy-butyrate (3-OBA) acts as a putative GPR81 antagonist and can effectively be used to block the lactate/GPR81 pathway, with the protection of cells from glucose deprivation [18]. This evidence concerns the gene HCAR1 and brain ischemia.